UBS Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,875
| Closed | -$5.98K | – | 8947 |
|
|
2023
Q2 | $5.98K | Sell |
6,875
-8,930
| -57% | -$7.77K | ﹤0.01% | 6332 |
|
|
2023
Q1 | $11K | Buy |
15,805
+7,492
| +90% | +$5.24K | ﹤0.01% | 6441 |
|
|
2022
Q4 | $6.82K | Sell |
8,313
-53,814
| -87% | -$44.1K | ﹤0.01% | 7788 |
|
|
2022
Q3 | $65K | Sell |
62,127
-118,555
| -66% | -$124K | ﹤0.01% | 5036 |
|
|
2022
Q2 | $297K | Buy |
180,682
+100,246
| +125% | +$165K | ﹤0.01% | 3683 |
|
|
2022
Q1 | $236K | Sell |
80,436
-3,355
| -4% | -$9.84K | ﹤0.01% | 4258 |
|
|
2021
Q4 | $400K | Buy |
83,791
+66,176
| +376% | +$316K | ﹤0.01% | 4151 |
|
|
2021
Q3 | $134K | Buy |
17,615
+3,346
| +23% | +$25.5K | ﹤0.01% | 4558 |
|
|
2021
Q2 | $106K | Buy |
14,269
+2,803
| +24% | +$20.8K | ﹤0.01% | 4800 |
|
|
2021
Q1 | $90K | Buy |
11,466
+3,966
| +53% | +$31.1K | ﹤0.01% | 5056 |
|
|
2020
Q4 | $69K | Buy |
+7,500
| New | +$69K | ﹤0.01% | 4942 |
|
|
2019
Q4 | – | Sell |
-1,291
| Closed | -$2K | – | 7268 |
|
|
2019
Q3 | $2K | Buy |
+1,291
| New | +$2K | ﹤0.01% | 6799 |
|
|
2019
Q2 | – | Sell |
-2,470
| Closed | -$12K | – | 7216 |
|
|
2019
Q1 | $12K | Buy |
2,470
+427
| +21% | +$2.07K | ﹤0.01% | 5871 |
|
|
2018
Q4 | $9K | Sell |
2,043
-6,352
| -76% | -$28K | ﹤0.01% | 6376 |
|
|
2018
Q3 | $92K | Buy |
8,395
+6,913
| +466% | +$75.8K | ﹤0.01% | 4791 |
|
|
2018
Q2 | $24K | Buy |
+1,482
| New | +$24K | ﹤0.01% | 5659 |
|